Neuronal and Synaptic Dysfunction in Autism Spectrum Disorder and Intellectual Disability

個数:
電子版価格
¥20,320
  • 電子版あり

Neuronal and Synaptic Dysfunction in Autism Spectrum Disorder and Intellectual Disability

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 394 p.
  • 言語 ENG
  • 商品コード 9780128001097
  • DDC分類 616.85882071

Full Description

Neuronal and Synaptic Dysfunction in Autism Spectrum Disorder and Intellectual Disability provides the latest information on Autism spectrum disorders (ASDs), the lifelong neurodevelopmental disorders that present in early childhood and affect how individuals communicate and relate to others and their surroundings.

In addition, three quarters of ASD patients also manifest severe intellectual disability. Though certain genes have been implicated, ASDs remain largely a mystery, and research looking into causes and cellular deficits are crucial for better understanding of neurodevelopmental disorders.

Despite the prevalence and insidious nature of this disorder, this book remains to be an extensive resource of information and background on the state of current research in the field.

The book serves as a reference for this purpose, and discusses the crucial role synaptic activity plays in proper brain function. In addition, the volume discusses the neurodevelopmental synaptopathies and serves as a resource for scientists and clinicians in all biomedical science specialties. This research has been crucial for recent studies that have provided a rationale for the development of pharmacological agents able to counteract functional synaptic anomalies and potentially ameliorate some ASD symptoms.

Contents

Part 1. Autism spectrum disorders and Intellectual disability: Genetic and Non-Genetic Causes
1. Experimental tools for the identification of specific genes in autism spectrum disorders and intellectual disability - Yiping Shen and Xiaohong Gong
2. Genetic causes of autism spectrum disorders - Guillaume Huguet and Thomas Bourgeron
3. Genetics of X-linked intellectual disability - Luigi Boccuto and Charles E. Schwartz
4. Genetic causes of intellectual disability: the genes controlling cortical development - Yoann Saillour and Jamel Chelly
5. Immune Dysfunction in Autism Spectrum Disorder - Natalia V. Malkova and Elaine Y. Hsiao

Part 2. Function of Mutated Genes in Intellectual Disability (ID) and Autism
6. Synapse proteomes and disease: the MASC paradigm - Àlex Bayés and Seth GN Grant
7. The Function of MeCP2 and its Causality in Rett Syndrome - Janine Lamonica and Zhaolan Zhou
8. FMRP and the pathophysiology of fragile X syndrome - Stephanie A. Barnes, Sophie R. Thompson, Peter C. Kind and Emily K. Osterweil
9. X-linked ASDs and ID gene mutations - Edoardo Moretto, Maria Passafaro and Silvia Bassani
10. Shank3, Shank2, Shank1 mutations in ID and ASD - Chiara Verpelli and Michael J. Schmeisser
11. Mutations in synaptic adhesion molecules - Jaewon Ko, Caterina Montani, Carlo Sala and Eunjoon Kim
12. CNTNAP2 mutations in autism - Olga Peñagarikano
13. Planar cell polarity (PCP) gene mutations in Autism Spectrum Disorder, Intellectual Disabilities and Related Deletion/Duplication Syndromes - Nathalie Sans, Jérôme Ezan, Maité M. Moreau and Mireille Montcouquiol
14. Protocadherin mutations in neurodevelopmental disorders - Duyen Pham, Chuan Tan, Claire Homan, Lachlan Jolly and Jozef Gécz
15. Mutations of voltage-gated sodium channel genes SCN1A and SCN2A in epilepsy, intellectual disability, and autism - Kazuhiro Yamakawa
16. Oxytocin in the developing brain: relevance as disease-modifying treatment in autism spectrum disorders - Bice Chini, Marianna Leonzino and Valentina a Gigliucci

Part 3. Experimental Models, Clinicaland Pharmacological Aspects of Major ASDs and Intellectual Disability Syndromes
17. Mouse Behaviour and Models for Autism Spectrum Disorders - Maria Luisa Scattoni
18. The iPSC technology to study neurodevelopmental disorders - Alysson Renato Muotri
19. Rett syndrome: clinical aspects - Daniel Tarquinio and Alan K. Percy
20. Fragile-x syndrome - Elizabeth Berry-Kravis and Anne Hoffmann
21. Phelan-McDermid syndrome: clinical aspects - Katy Phelan, Luigi Boccuto and Sara Sarasua
22. Epilepsy associated with ASD and intellectual disability - Carla Marini

最近チェックした商品